Cencora Quarterly Balance Sheet
NYSE: CORHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cencora financial position
As of Jun 30, 2026, Cencora reported total assets of $83.81 billion, up 13.3% from a year earlier against total liabilities of $80.57 billion. Shareholders' equity stood at $3.05 billion, or 3.6% of assets. The company held $2.82 billion in cash and equivalents against $11.72 billion of debt, a net debt position of $8.91 billion.
The current ratio (current assets divided by current liabilities) was 0.93, meaning short-term obligations exceed short-term assets. Debt-to-equity was 3.84.
Summary generated from market data by MetaCap's automated system. Methodology
Cencora balance sheet (quarterly)
| Quarter (USD) | Q3 20262026-06-30 | Q2 20262026-03-31 | Q1 20262025-12-31 | Q4 20252025-09-30 | Q3 20252025-06-30 | Q2 20252025-03-31 | Q1 20252024-12-31 | Q4 20242024-09-30 | Q3 20242024-06-30 | Q2 20242024-03-31 | Q1 20242023-12-31 | Q4 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.82B | 2.18B | 1.75B | 4.36B | 2.23B | 1.98B | 3.22B | 3.13B | 3.31B | 2.07B | 2.87B | 2.59B |
| Receivables | 25.45B | 24.89B | 25.98B | 25.23B | 24.56B | 23.72B | 24.55B | 23.87B | 24.05B | 22.64B | 21.58B | 20.91B |
| Inventory | 21.03B | 20.01B | 24.08B | 20.49B | 20.14B | 18.97B | 20.51B | 19.00B | 18.30B | 17.63B | 18.65B | 17.45B |
| Total Current Assets | 55.34B | 53.14B | 54.15B | 52.24B | 48.81B | 46.53B | 49.99B | 47.72B | 47.31B | 44.16B | 44.86B | 42.80B |
| Property, Plant & Equipment | 2.84B | 2.81B | 2.45B | 2.54B | 2.43B | 2.30B | 2.10B | 2.18B | 2.08B | 2.09B | 2.12B | 2.14B |
| Goodwill | 16.52B | 16.45B | 13.73B | 13.68B | 14.33B | 14.09B | 9.18B | 9.32B | 9.61B | 9.62B | 9.66B | 9.57B |
| Intangible Assets | 5.93B | 6.05B | 3.68B | 3.77B | 3.93B | 3.86B | 3.68B | 4.00B | 4.01B | 4.18B | 4.38B | 4.43B |
| Total Assets | 83.81B | 81.65B | 78.36B | 76.59B | 73.96B | 71.19B | 69.05B | 67.10B | 66.77B | 63.87B | 64.69B | 62.56B |
| Accounts Payable | 54.70B | 51.88B | 56.06B | 54.72B | 51.04B | 50.11B | 49.91B | 50.94B | 49.88B | 46.32B | 47.74B | 45.84B |
| Short-Term Debt | 279.15M | 202.66M | 342.28M | 117.78M | 196.79M | 770.32M | 2.21B | 576.33M | 565.11M | 1.07B | 592.78M | 641.34M |
| Total Current Liabilities | 59.20B | 56.13B | 59.13B | 57.82B | 53.96B | 53.33B | 54.51B | 54.28B | 52.97B | 49.76B | 50.77B | 48.83B |
| Long-Term Debt | 11.44B | 12.18B | 7.58B | 7.54B | 8.04B | 7.09B | 5.94B | 3.81B | 4.17B | 4.18B | 4.19B | 4.15B |
| Total Liabilities | 80.57B | 78.07B | 76.27B | 74.84B | 71.75B | 70.01B | 68.69B | 66.31B | 65.71B | 62.64B | 63.63B | 61.89B |
| Shareholders' Equity | 3.05B | 3.40B | 1.91B | 1.51B | 1.98B | 1.01B | 226.58M | 645.94M | 925.21M | 1.08B | 911.70M | 522.00M |
| Retained Earnings | 9.14B | 8.49B | 6.97B | 6.53B | 6.98B | 6.40B | 5.79B | 5.42B | 5.51B | 5.13B | 4.82B | 4.32B |
| Total Debt | 11.72B | 12.39B | 7.92B | 7.66B | 8.24B | 7.86B | 8.15B | 4.39B | 4.73B | 5.25B | 4.78B | 4.79B |
| Net Cash (Debt) | -8.91B | -10.21B | -6.17B | -3.30B | -6.01B | -5.88B | -4.92B | -1.26B | -1.42B | -3.18B | -1.91B | -2.20B |
| Shares Outstanding | 190.83M | 194.56M | 194.52M | 193.94M | 193.86M | 193.78M | 193.85M | 194.94M | 197.01M | 199.39M | 199.46M | 200.81M |
This table shows 12 quarterly periods of Cencora's balance sheet, from Q3 2026 back to Q4 2023, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow COR's reporting calendar. What is a balance sheet?